Barclays PLC Generation Bio Co. Transaction History
Barclays PLC
- $288 Billion
- Q1 2024
A detailed history of Barclays PLC transactions in Generation Bio Co. stock. As of the latest transaction made, Barclays PLC holds 37,405 shares of GBIO stock, worth $105,482. This represents 0.0% of its overall portfolio holdings.
Number of Shares
37,405
Previous 67,861
44.88%
Holding current value
$105,482
Previous $112,000
35.71%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding GBIO
# of Institutions
79Shares Held
49.5MCall Options Held
20.3KPut Options Held
0-
Price T Rowe Associates Inc Baltimore, MD8.88MShares$25 Million0.0% of portfolio
-
Atlas Venture Life Science Advisors, LLC8.28MShares$23.3 Million4.22% of portfolio
-
Bellevue Group Ag Kuesnacht, V83.86MShares$10.9 Million0.25% of portfolio
-
Black Rock Inc. New York, NY3.05MShares$8.6 Million0.0% of portfolio
-
Bank Of America Corp Charlotte, NC2.99MShares$8.43 Million0.0% of portfolio
About Generation Bio Co.
- Ticker GBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,011,200
- Market Cap $166M
- Description
- Generation Bio Co., a genetic medicines company, develops therapies for the treatment of rare and prevalent diseases. The company provides a portfolio of programs, including programs for rare and prevalent diseases of the liver and retina. It also focuses on the diseases of skeletal muscle, central nervous system, and oncology. The company was f...